⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANRO News
Alto Neuroscience Inc.
CData Expands Connect AI Platform with New Agent Tooling and Enterprise-Grade Security to Power Production AI Deployments
prnewswire.com
MSFT
ANRO
DBX
GOOG
PLTR
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders
prnewswire.com
HELP
AXSM
RLMD
ANRO
CMPS
BREAKER RAISES $6M IN SEED ROUND TO SOLVE DEFENSE'S AUTONOMOUS ORCHESTRATION PROBLEM
prnewswire.com
RKLB
ANRO
SHOP
Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia
businesswire.com
ANRO
Vascular Access Device Market worth $8.68 billion by 2031 | MarketsandMarkets™
prnewswire.com
BDX
TFX
ICUI
ANRO
MMSI
MCI
CCK
Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment
businesswire.com
ANRO
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Replimune Group, Inc. (REPL), and Fly-E Group, Inc. (FLYE)
globenewswire.com
ANRO
ATKR
REPL
FLYE
Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression
businesswire.com
ANRO
Lancering van Owkin's gespecialiseerde biologische Pathology Explorer AI-agent met Claude voor de gezondheidszorg en biowetenschappen van Anthropic
businesswire.com
ANRO
United States Atherectomy Devices Market Report 2025-2033: Shares for Product Types, Applications, End Users, Top States
globenewswire.com
BSX
ABT
MDT
CAH
TER
BDX
ANRO